Peter Bodary, Ph.D.
Lecturer, Movement Science
3730 CCRB
401 Washtenaw Ave.
Ann Arbor, MI 48109-2214
Phone: (734) 615-8071
Fax: (734) 936-1925
pfbodary@umich.edu
Office Hours (Fall 2008):
Tu 1:30-2:30pm
Th 1:30-2:30pm
Full vita>>
Laboratory:
Areas of Interest
Short Description: Obesity, diabetes, adipose tissue and cardiovascular disease complications.
Back to Top
Educational Background
University of Michigan Medical Center, Ann Arbor, MI
Division of Cardiovascular Medicine, Cardiovascular Research Center
Research Fellow, 2000–2002
University of South Carolina, Columbia, SC
Ph.D., School of Public Health, Dept.of Exercise Science, 2000
University of Toledo, Toledo, OH
M.S., Dept. of Health Promotion and Human Performance, 1994
Grand Valley State University, Allendale, MI
B.S., Health Science, 1992
Back to Top
Research
- Role of leptin receptor signaling pathways on arterial thrombosis and atherogenesis
- The Pharmacologic Treatment of Fabry Disease
- Effects of pioglitazone on the development of arterial thrombosis in mouse models of insulin resistance and atherosclerosis
- Leptin in Vascular Disease
Back to Top
Teaching
MOVESCI 340. Exercise Physiology
MOVESCI 449. Laboratory Rotation in Exercise Physiology
Back to Top
Honors and Awards
2005 Junior Faculty Award, American Diabetes Association
2004 Young Investigator Prize for Thrombosis, American Heart Association
2001, 2002 Internal Medicine Research Day Award, University of Michigan
1999 Doctoral Student Summer Dissertation Fellowship, University of South Carolina
Back to Top
Professional Affiliations and Service
|
Membership in Professional Societies |
| |
American Diabetes Association |
| |
American Heart Association, Council on Nutrition, Metabolism, and Physical Activity |
| |
American Heart Association, Council on Arteriosclerosis, Thrombosis, and Vascular Biology |
|
Ad Hoc Reviewer of Manuscripts |
| |
British Journal of Sports Medicine |
| |
Canadian Journal of Applied Physiology |
| |
Circulation |
| |
Journal of Applied Physiology |
| |
International Journal of Sports Medicine |
| |
Medicine & Science in Sports & Exercise |
| |
Arteriosclerosis, Thrombosis & Vascular Biology |
| |
Diabetes |
| |
Diabetes Care |
| |
AJP – Endocrinology and Metabolism |
| |
Thrombosis and Haemostasis |
Back to Top
Selected Publications
Bodary PF. Invited Review: “Links between adipose tissue and thrombosis in the mouse.” Arterioscler Thromb Vasc Biol. 2007; 27(11): 2284-91.
Bodary PF, Iglay HB, Eitzman DT. Invited Review: “Strategies to Reduce Vascular Risk Associated with Obesity.” Curr Vasc Pharmacol. 2007; 5(4): 249-58.
Brook RD, Bard RL, Bodary PF, Eitzman DT, Rajagopalan S, Sun Y, Depaoli AM. “Blood pressure and vascular effects of leptin in humans.” Metab Syndr Relat Disord. 2007 Sep;5(3):270-4.
Brook RD, Bard RL, Kehrer C, Bodary PF, Eitzman DT, Rajagopalan S. “Valsartan Improves Insulin Sensitivity without Altering Vascular Function in Healthy Overweight Adults without the Metabolic Syndrome.” Metab Syndr Relat Disord. 2007 Sep;5(3):255-61.
Bodary PF, Shayman JA, and Eitzman DT. Invited review: “Alpha-galactosidase A and Vascular Disease.” Trends Cardiovasc Med. 2007; 17(4):129-33.
Bodary PF, Homeister JW, Vargas FB, Wickenheiser KJ, Cudney SS, Bahrou KL, Öhman M, Rabbani AB, Eitzman DT. “Generation of Soluble P-and E-Selectins In Vivo Is Dependent on Expression of P- Selectin Glycoprotein Ligand-1.” J Thromb Haemost. 2007; 5(3):599-603.
Bodary PF, Shen Y, Öhman M, Bahrou KL, Vargas FB, Cudney SS, Wickenheiser KJ, Myers MG Jr, Eitzman DT. “Leptin Regulates Neointima Formation After Arterial Injury Through Mechanisms Independent of Blood Pressure and the Leptin Receptor/STAT3 Signaling Pathways Involved in Energy Balance.” Arterioscler Thromb Vasc Biol. 2007; (1):70-6.
Shen Y-C, Bodary PF, Vargas FB, Homeister JW, Gordon D, Ostenso KA, Shayman JA, Eitzman, DT. “Alpha galactosidase a deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V leiden mutation.” Stroke. 2006; 37(4): 1106-8.
Bodary PF, Eitzman DT. “Adiponectin: vascular protection from the fat?” Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):235-6.
Bodary PF, Sambaziotis C, Wickenheiser KJ, Rajagopalan S, Pitt B, Eitzman DT. “Aldosterone promotes thrombosis formation following arterial injury in mice.” Arterioscler Thromb Vasc Biol. 2006; 26(1):233.
Back to Top
Selected Grants
1/2005–12/2009. Co-investigator, NIH/NIDDK, RO1-DK55823. “The Pharmacologic Treatment of Fabry Disease.” Principal Investigator: James A. Shayman, MD.
7/1/2005–6/2008. Principal Investigator, American Diabetes Association, 7-05-JF-04. “Role of leptin receptor signaling pathways on arterial thrombosis and atherogenesis.” Principal Investigator: Peter F. Bodary, Ph.D.
Sub–award: Faculty Mentor, American Diabetes Association. Undergraduate Minority Internship Award. Principal Investigator: Peter F. Bodary, Ph.D.
4/2003–3/2008 Co-investigator, NIH/NHLBI, R01-HL073150-01
(renewal submitted) “Leptin in Vascular Disease.”
Principal Investigator: Daniel T. Eitzman, M.D.
11/2002–10/2004. Co-investigator, Takeda Pharmaceuticals. Effort: 25%
“Effects of pioglitazone on the development of arterial thrombosis in mouse models of insulin resistance and atherosclerosis.”
Principal Investigator: Daniel T. Eitzman, M.D.
Back to Top
Links
American Diabetes Association
American Heart Association, Council on Nutrition, Metabolism, and Physical Activity
American Heart Association, Council on Arteriosclerosis, Thrombosis, and Vascular Biology
Back to Top
|
